NeuroOne® Reports Second Quarter Fiscal Year 2025 Financial Results; Gross Margin Improves Significantly YoY to 55.6%
Filed 510 ( k ) Submission with FDA for OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain Ahead of Schedule ...
Caliber Hospitality Development Launches to Pursue Opportunistic and Distressed Hotel Investments - CaliberCos ( NASDAQ:CWD )
SCOTTSDALE, Ariz., May 13, 2025 ( GLOBE NEWSWIRE ) -- Caliber CWD, a real estate investor, developer, and manager, today announced the launch of Caliber Hospitality Development, LLC ( "CHD" ) , a joint venture between Caliber and GIA Hospitality, LLC ( "GIA" ) .
Caliber Hospitality Development Launches to Pursue Opportunistic and Distressed Hotel Investments
Caliber & GIA Hospitality Partner in Strategic Joint Venture Caliber & GIA Hospitality Partner in Strategic Joint Venture ...
UNISYNC Reports Q2 Fiscal 2025 Operating Results Showing Continued Improvement in Profitability
TORONTO, May 13, 2025 ( GLOBE NEWSWIRE ) -- Unisync Corp. ( "Unisync" ) ( TSX:"UNI" ) ( OTC:"USYNF" ) is pleased to report a net income before tax of $1.0 million ( $0.05/share ) and an Adjusted EBITDA of $3.1 million ( $0.16/share ) on revenues of $24.5 million for the three months ended March ...
Stardust Power Confirms No Industrial Wastewater Permit Required for Oklahoma Lithium Facility
GREENWICH, Conn., May 13, 2025 ( GLOBE NEWSWIRE ) -- Stardust Power Inc. ( "Stardust Power" or the "Company" ) , an American developer of battery-grade lithium products, today announced a significant update to its permitting process.
MediWound Announces Publication of Phase II EscharEx® Data Demonstrating Superiority Over Collagenase in Venous Leg Ulcers
Post hoc analysis published in the peer-reviewed journal Wounds highlights EscharEx®'s superior clinical performance and comparable safety profile to SANTYL® Post hoc analysis published in the peer-reviewed journal Wounds highlights EscharEx®'s superior clinical performance and comparable safety ...
FAVO Capital Announces Conversion of Super Voting Series C Shares to Common Stock
FORT LAUDERDALE, Fla., May 13, 2025 ( GLOBE NEWSWIRE ) -- via IBN -- FAVO Capital, Inc. ( OTC: FAVO ) , a publicly traded private credit firm specializing in merchant cash advances ( MCAs ) and revenue-based financing for underserved small and medium-sized businesses ( SMBs ) , today announced ...
Bicara Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
Updated data from ongoing Phase 1/1b trial in 1L R/M HNSCC to be presented at 2025 ASCO Annual Meeting ...




